Content about Scott Melville

March 1, 2013
CHPA's 2013 Annual Executive Conference puts focus on 'consumer centricity'

DSN sat down with Scott Melville, CHPA president and CEO, to discuss the Consumer Healthcare Products Association 2013 Annual Executive Conference and how the conference will focus on "consumer centricity," in this exclusive podcast. In addition, senior-level executives attending the sold-out conference will learn how CHPA is extolling that value on Capitol Hill. "OTCs are demonstrating their value everyday because consumers are purchasing them with their own dollars," Melville said. "The challenge has been for policy-makers to understand the value that OTC medicines bring." But that may change this year, Melville said, as CHPA continues to lobby around that OTC value quotient.

Audio Q&A: DSN sat down with Scott Melville, CHPA president and CEO, in this exclusive podcast to discuss the Consumer Healthcare Products Association 2013 Annual Executive Conference and how the conference will focus on "consumer centricity." In addition, senior-level executives attending the sold-out conference will learn how CHPA is extolling that value on Capitol Hill.

March 6, 2012
CHPA talks 'game change'

"Game change." That's the theme leading up to the Consumer Healthcare Products Association's 2012 Annual Executive Conference given the shifts in consumer demand and legislative focus. DSN caught up with CHPA's president and CEO Scott Melville before the meeting to get a sense of where the business of consumer healthcare products stands today, and what the association is working toward tomorrow.

AUDIO Q&A: "Game change." That's the theme leading up to the Consumer Healthcare Products Association's 2012 Annual Executive Conference given the shifts in consumer demand and legislative focus. DSN caught up with CHPA's president and CEO Scott Melville before the meeting to get a sense of where the business of consumer healthcare products stands today, and what the association is working toward tomorrow.

March 22, 2013
Senators introduce bill restricting sale of DXM cough-relieving ingredient to adults

Sens. Bob Casey, D-Pa., and Lisa Murkowski, R-Ark., on Friday introduced the Preventing Abuse of Cough Treatments Act of 2013, which would require retailers to restrict the sale of dextromethorphan-containing products to adults.

WASHINGTON — Sens. Bob Casey, D-Pa., and Lisa Murkowski, R-Ark., on Friday introduced the Preventing Abuse of Cough Treatments Act of 2013, which would require retailers to restrict the sale of dextromethorphan-containing products to adults. The bill also would restrict the sale of raw, bulk DXM to FDA-approved entities. 

Many retailers have age restrictions on the sale of DXM products already in place; and similar legislation to this has been enforced in California since 2012. 

March 14, 2013
Merck's James Mackey elected CHPA chairman

The Consumer Healthcare Products Association officially elected James Mackey, SVP U.S. region head for Merck Consumer Care, as the association's chairman.

NAPLES, Fla. — The Consumer Healthcare Products Association on Wednesday officially elected James Mackey, SVP U.S. region head for Merck Consumer Care, as the association's chairman. Paul Sturman, president and general manager Pfizer Consumer Healthcare, will serve as immediate past chairman. 

March 12, 2013
CHPA: OTC industry well-positioned to seize self-care opportunity

The Consumer Healthcare Products Association's Annual Executive Conference was sold out for the first time since 2001, CHPA president and CEO Scott Melville told a packed morning session, and that is a strong prognosticator as to the health and vitality of the self-care industry.

NAPLES, Fla. — The Consumer Healthcare Products Association's Annual Executive Conference was sold out for the first time since 2001, CHPA president and CEO Scott Melville told a packed morning session, and that is a strong prognosticator as to the health and vitality of the self-care industry. 

March 6, 2013
Survey: Most practitioners recommend OTC before prescription-only

Nearly 98% of primary care physicians, nurse practitioners and pharmacists trust and recommend over-the-counter medicines to their patients, according to a new survey released Wednesday by the Consumer Healthcare Products Association.

WASHINGTON — Nearly 98% of primary care physicians, nurse practitioners and pharmacists trust and recommend over-the-counter medicines to their patients, according to a new survey released Wednesday by the Consumer Healthcare Products Association. Nearly three-fourths of primary care physicians recommend OTC medicines to relieve symptoms before recommending a prescription treatment.

March 1, 2013
CHPA: Prescription-only PSE requirements would be burden to consumers

The Consumer Healthcare Products Association on Friday released a statement regarding a poll released last week by the Asthma and Allergy Foundation of America.

WASHINGTON — The Consumer Healthcare Products Association on Friday released a statement regarding a poll released last week by the Asthma and Allergy Foundation of America. 

February 15, 2013
GAO issues report on the impact PSE sales restrictions have on meth labs

According to a report filed to Congress by the Government Accountability Office on Wednesday, the seizures of methamphetamine-producing labs declined following state and federal sales restrictions on pseudoephedrine.

WASHINGTON — According to a report filed to Congress by the Government Accountability Office on Wednesday, the seizures of methamphetamine-producing labs declined following state and federal sales restrictions on pseudoephedrine. And while electronic tracking systems help enforce PSE sales limits, those efforts have not reduced meth lab incidents and have limitations related to smurfing, the GAO added. 

January 25, 2013
Merck: FDA approves Oxytrol for Women, creating overactive bladder category in OTC

Merck on Friday announced the Food and Drug Administration has approved the switch of Oxytrol for Women (oxybutynin transdermal system, 3.9 mg/day) from prescription-only to nonprescription, creating a new category — overactive bladder in women — in the OTC area.

WHITEHOUSE STATION, N.J. — Merck on Friday announced the Food and Drug Administration has approved the switch of Oxytrol for Women (oxybutynin transdermal system, 3.9 mg/day) from prescription-only to nonprescription, creating a new category — overactive bladder in women — in the OTC area. Most notable about this switch is the fact that the FDA approved Oxytrol for Women against the majority opinion of its Nonprescription Drug Advisory Committee, which voted five in favor and six opposed to the switch in November. 

December 27, 2012
Ohio becomes 25th state to adopt NPLEx

The Consumer Healthcare Products Association last week applauded Ohio Gov. John Kasich for signing into law House Bill 334, an anti-methamphetamine bill authored by Reps. Terry Johnson, R-Portsmouth, and Danny Bubp, R-West Union.

WASHINGTON — The Consumer Healthcare Products Association last week applauded Ohio Gov. John Kasich for signing into law House Bill 334, an anti-methamphetamine bill authored by Reps. Terry Johnson, R-Portsmouth, and Danny Bupb, R-West Union. With the new law, Ohio now becomes the 25th state to adopt real-time, stop-sale technology known as the National Precursor Log Exchange.

December 27, 2012
Survey: DXM abuse among high school students holds steady at just under 5%

The National Institute on Drug Abuse last week released the 2012 Monitoring the Future survey, finding that 5.6% of high school seniors, 3% of eighth graders and 4.7% of tenth graders abused over-the-counter cough and cold medicines containing dextromethorphan, bringing the overall average to under 5%.

BETHESDA, Md. — The National Institute on Drug Abuse last week released the 2012 Monitoring the Future survey, finding that 5.6% of high school seniors abused over-the-counter cough and cold medicines containing dextromethorphan, a rate that has held relatively steady over the past five years. Abuse of DXM products was reported to be 3% among eighth graders and 4.7% among tenth graders, bringing the overall average to under 5%.

July 11, 2012
Senate introduces bill to restrict DXM sales to adults

Sens. Bob Casey, D.-Pa., and Lisa Murkowski, R-Alaska, on Wednesday introduced bipartisan legislation to prevent the abuse of cough syrup to get high by restricting the sale of products containing dextromethorphan to adults older than 18 years of age.

WASHINGTON — Sens. Bob Casey, D.-Pa., and Lisa Murkowski, R-Alaska, on Wednesday introduced bipartisan legislation to prevent the abuse of cough syrup to get high by restricting the sale of products containing dextromethorphan to adults older than 18 years of age.

May 31, 2012
House committee approves measure to restore OTC reimbursements under FSAs

The House Ways and Means Committee on Thursday approved the Restoring Access to Medication Act (H.R. 5842), which would repeal the provision of the Patient Protection and Affordable Care Act that disqualified expenses for over-the-counter drugs as eligible for reimbursement under health savings accounts and flexible spending arrangements without a prescription.

WASHINGTON — The House Ways and Means Committee on Thursday approved the Restoring Access to Medication Act (H.R. 5842), which would repeal the provision of the Patient Protection and Affordable Care Act that disqualified expenses for over-the-counter drugs as eligible for reimbursement under health savings accounts and flexible spending arrangements without a prescription.

May 29, 2012
House to consider repealing prescription mandate on OTCs purchased through FSAs

The House of Representatives will vote to repeal limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medications as early as June 4, according to a report published online by The Hill, a Washington, D.C.-based political newspaper.

WASHINGTON — The House of Representatives will vote to repeal limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medications as early as June 4, according to a report published online by The Hill, a Washington, D.C.-based political newspaper.

The paper cited a planning memo from majority leader Eric Cantor, R-Va.

April 25, 2012
CHPA leader urges House subcommittee to restore FSA OTC coverage

The Consumer Healthcare Products Association on Wednesday testified before a House subcommittee to urge legislators to restore over-the-counter medicines' eligibility under flexible spending accounts.

WASHINGTON — The Consumer Healthcare Products Association on Wednesday testified before a House subcommittee to urge legislators to restore over-the-counter medicines' eligibility under flexible spending accounts.

April 9, 2012
Idaho joins National Precursor Log Exchange in its fight against PSE diversion

Idaho on Monday became state No. 21 to adopt the real-time, stop-sale technology National Precursor Log Exchange in its battle against the diversion of the cough-cold ingredient pseudoephedrine to methamphetamine.

WASHINGTON — Idaho on Monday became state No. 21 to adopt the real-time, stop-sale technology National Precursor Log Exchange in its battle against the diversion of the cough-cold ingredient pseudoephedrine to methamphetamine.

March 7, 2012
Natural product advocate joins CHPA as new VP government affairs

The Consumer Healthcare Products Association on Tuesday named John Gay as the association's VP government affairs.

WASHINGTON — The Consumer Healthcare Products Association on Tuesday named John Gay as the association's VP government affairs. Gay will begin his duties March 8.

Reporting to CHPA president and CEO Scott Melville, Gay will oversee the association’s state and federal government affairs departments, its political action committee, and will serve as a member of the association’s senior management team.

February 22, 2012
Study: Prescription-only PSE laws have no impact on number of meth labs, meth abusers

Prescription-only pseudoephedrine regulation has no impact on the methamphetamine trade, according to a Cascade Policy Institute study on the 2005 Oregon law, which restricts access to medicines containing pseudoephedrine.

PORTLAND, Ore. — Prescription-only pseudoephedrine regulation has no impact on the methamphetamine trade, according to a Cascade Policy Institute study on the 2005 Oregon law, which restricts access to medicines containing pseudoephedrine.

February 17, 2012
Oklahoma impact study: Rx-PSE would increase health costs without reducing meth issue

According to a report prepared last month by the Economic Impact Group discerning the impact prescription-only pseudoephedrine would have on Oklahoma citizens, prescription-only PSE would result in almost 300,000 additional doctor's office visits at an estimated cost reaching $60 million; $6 million would be directly borne by consumers.

EDMOND Okla. — According to a report prepared last month by the Economic Impact Group discerning the impact prescription-only pseudoephedrine would have on Oklahoma citizens, prescription-only PSE would result in almost 300,000 additional doctor's office visits at an estimated cost reaching $60 million; $6 million would be directly borne by consumers.

January 31, 2012
For every $1 spent on OTCs, the healthcare system saves up to $7

For every dollar spent on over-the-counter medicines, the U.S. healthcare system realizes a savings of between $6 and $7, or $102 billion all told, the Consumer Healthcare Products Association announced Tuesday with the release of this new study, "The Value of OTC Medicine to the United States."

WASHINGTON — For every dollar spent on over-the-counter medicines, the U.S. healthcare system realizes a savings of between $6 and $7, or $102 billion all told, the Consumer Healthcare Products Association announced Tuesday with the release of this new study, "The Value of OTC Medicine to the United States."

November 4, 2011
Op-ed: CHPA, AMA call on Congress to repeal OTC Rx-only FSA provision

The Consumer Healthcare Products Association last week teamed up with the American Medical Association in a joint op-ed published in Roll Call that called for the repeal of the over-the-counter prescription requirement for flexible spending accounts.

WASHINGTON — The Consumer Healthcare Products Association last week teamed up with the American Medical Association in a joint op-ed published in Roll Call that called for the repeal of the over-the-counter prescription requirement for flexible spending accounts.

September 26, 2011
Senate designates October National Medicine Abuse Awareness Month

The U.S. Senate last week adopted a resolution designating the month of October 2011 as “National Medicine Abuse Awareness Month” to raise attention to the problem of prescription medicine abuse, especially by teenagers.

WASHINGTON — The U.S. Senate last week adopted a resolution designating the month of October 2011 as “National Medicine Abuse Awareness Month” to raise attention to the problem of prescription medicine abuse, especially by teenagers.

September 1, 2011
California bans sale of dextromethorphan to minors

California on Wednesday banned the sale of dextromethorphan to minors, becoming the first state to pass such legislation.

SACRAMENTO, Calif. — California on Wednesday banned the sale of dextromethorphan to minors, becoming the first state to pass such legislation.

May 11, 2011
Missouri's Rx-only PSE legislation moves to state Senate

Missouri’s House of Representatives on Monday voted 100 in favor and 50 opposed to reclassifying pseudoephedrine as a prescription-only remedy and subsequently moved the matter to the state Senate.

ST. LOUIS — Missouri’s House of Representatives on Monday voted 100 in favor and 50 opposed to reclassifying pseudoephedrine as a prescription-only remedy and subsequently moved the matter to the state Senate — this despite the fact that electronic track-and-trace has been up and running for the past six months, blocking more than 30,000 potentially illegal PSE purchases, stated Scott Melville, president and CEO of the Consumer Healthcare Products Association.

March 24, 2011
Got OTC?

The Consumer Healthcare Products Association may not be painting pink Pepto-Bismol mustaches on a group of Hollywood celebrities and professional athletes as part of the new campaign it plans to fully unveil in June, but the goal is more or less the same as the “Got Milk?” ads.

“Got milk?” has become ubiquitous. There is 100% clarity of message. The milk mustache says it all: Milk is an essential food and an integral part of a healthy diet; it HAS TO BE in your refrigerator, on your breakfast table and in your lunch box.